ANVS - Annovis Bio, Inc.

QQQ $ 624.22 $ 0.00 (0 %)

DIA $ 470.15 $ 0.00 (0 %)

SPY $ 676.56 $ 0.00 (0 %)

TLT $ 89.85 $ 0.00 (0 %)

GLD $ 367.50 $ 0.00 (0 %)

Previous Close

$ 2.02

Open

$ 2.08

Bid

$ 1.90 x 500

Ask

$ 2.15 x 100

Day's Range

-- - --

52 Week Range

$ 1.11 - $ 9.23

Volume

275,154

Average Volume

Market Cap

39.36M

Beta (5Y Monthly)

$ 1.93

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-21-2025	12-31-2024	10-K
4	11-08-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-10-2024	03-31-2024	10-Q
7	03-29-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	03-31-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-04-2022	03-31-2022	10-Q
15	03-02-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	07-28-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	03-03-2021	12-31-2020	10-K
20	11-04-2020	09-30-2020	10-Q
21	07-29-2020	06-30-2020	10-Q
22	05-05-2020	03-31-2020	10-Q
23	03-25-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Friday's I...
10/10/2025 17:06:47

Annovis Bio Announces $6M Registered Direc...
10/10/2025 12:36:43

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneer...

Annovis Bio Announces Results Showing Bunt...
10/09/2025 11:34:07

Canaccord Genuity Maintains Buy on Annovis...
09/30/2025 13:41:11

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and maintains $17 price target.

Annovis Bio Appoints Mark Guerin As CFO
09/25/2025 11:37:09

Annovis Bio Highlights New Buntanetap Form...
09/16/2025 11:38:43

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneer...

alphabet-to-rally-around-23-here-are-10-top-analyst-forecasts-for-wednesday

Alphabet To Rally Around 23%? Here Are 10 ...
09/03/2025 12:25:40

HC Wainwright & Co. Maintains Buy on Annov...
09/03/2025 10:56:11

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target ...

Annovis Bio Q2 EPS $(0.32) Beats $(0.40) E...
08/12/2025 20:37:11

Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.40) by ...

Annovis Transfers Full Patent To Crystal B...
08/07/2025 12:06:06

Annovis achieves comprehensive intellectual property (IP) protection now covering both the original semi-crystalline and new cr...

why-medpace-shares-are-trading-higher-by-45-here-are-20-stocks-moving-premarket

Why Medpace Shares Are Trading Higher By 4...
07/22/2025 09:39:38

12 Health Care Stocks Moving In Wednesday'...
06/25/2025 17:06:36

Annovis Bio Announces It Received NYSE Acc...
06/19/2025 10:38:15

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneer...

HC Wainwright & Co. Maintains Buy on Annov...
06/09/2025 12:00:13

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target ...

'FDA Clears First Blood Test Used In Diagn...
05/16/2025 17:32:57

https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease#:~:text=The%...

levi-strauss-to-rally-around-20-here-are-10-top-analyst-forecasts-for-thursday

Levi Strauss To Rally Around 20%? Here Are...
05/15/2025 12:32:50

Canaccord Genuity Maintains Buy on Annovis...
05/15/2025 12:14:44

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $26 ...

Annovis Bio Q1 EPS $(0.32) Beats $(0.36) E...
05/13/2025 20:47:25

Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.36) by ...

12 Health Care Stocks Moving In Monday's A...
04/21/2025 21:05:49

12 Health Care Stocks Moving In Monday's I...
04/21/2025 17:05:41